Prospects for new and emerging therapeutics in severe asthma: the role of biologics.

Abstract

INTRODUCTION Asthma is a common and heterogeneous disease. While current conventional therapies are effective in the majority of the patients, a significant subgroup remain uncontrolled despite these treatments. Different biological agents are currently approved or undergoing development for treatment of asthma, including anti-IgE, anti-interleukin (IL)-5… (More)
DOI: 10.1080/17476348.2017.1326821

Topics

1 Figure or Table

Slides referencing similar topics